These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 37317585)
1. Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: An analysis from the Swedish Heart Failure Registry. Schrage B; Lund LH; Benson L; Braunschweig F; Ferreira JP; Dahlström U; Metra M; Rosano GMC; Savarese G Eur J Heart Fail; 2023 Jul; 25(7):1132-1144. PubMed ID: 37317585 [TBL] [Abstract][Full Text] [Related]
2. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden). Savarese G; Bodegard J; Norhammar A; Sartipy P; Thuresson M; Cowie MR; Fonarow GC; Vaduganathan M; Coats AJS Eur J Heart Fail; 2021 Sep; 23(9):1499-1511. PubMed ID: 34132001 [TBL] [Abstract][Full Text] [Related]
3. Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients. Srivastava PK; DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; Hernandez AF; Fonarow GC JACC Heart Fail; 2021 Jan; 9(1):28-38. PubMed ID: 33309579 [TBL] [Abstract][Full Text] [Related]
4. Use of and association between heart failure pharmacological treatments and outcomes in obese versus non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry. Cappelletto C; Stolfo D; Orsini N; Benson L; Rodolico D; Rosano GMC; Dahlström U; Sinagra G; Lund LH; Savarese G Eur J Heart Fail; 2023 May; 25(5):698-710. PubMed ID: 36781199 [TBL] [Abstract][Full Text] [Related]
5. Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP-HF registry. Tomasoni D; Pagnesi M; Colombo G; Chiarito M; Stolfo D; Baldetti L; Lombardi CM; Adamo M; Maggi G; Inciardi RM; Loiacono F; Maccallini M; Villaschi A; Gasparini G; Montella M; Contessi S; Cocianni D; Perotto M; Barone G; Merlo M; Cappelletti AM; Rosano G; Sinagra G; Pini D; Savarese G; Metra M Eur J Heart Fail; 2024 Feb; 26(2):327-337. PubMed ID: 37933210 [TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry. Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971 [TBL] [Abstract][Full Text] [Related]
7. Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community. Dunlay SM; Killian JM; Roger VL; Schulte PJ; Blecker SB; Savitz ST; Redfield MM J Card Fail; 2022 Oct; 28(10):1500-1508. PubMed ID: 35902033 [TBL] [Abstract][Full Text] [Related]
8. Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF). Savarese G; Kishi T; Vardeny O; Adamsson Eryd S; Bodegård J; Lund LH; Thuresson M; Bozkurt B JACC Heart Fail; 2023 Jan; 11(1):1-14. PubMed ID: 36202739 [TBL] [Abstract][Full Text] [Related]
9. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease. Cutshall BT; Duhart BT; Saikumar J; Samarin M; Hutchison L; Hudson JQ Am J Med Sci; 2018 Mar; 355(3):247-251. PubMed ID: 29549927 [TBL] [Abstract][Full Text] [Related]
11. Impact of Pharmacist-Led Heart Failure Clinic on Optimization of Guideline-Directed Medical Therapy (PHARM-HF). Patil T; Ali S; Kaur A; Akridge M; Eppes D; Paarlberg J; Parashar A; Jarmukli N J Cardiovasc Transl Res; 2022 Dec; 15(6):1424-1435. PubMed ID: 35501544 [TBL] [Abstract][Full Text] [Related]
12. Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction. Lee YC; Lin JK; Ko D; Cheng S; Patorno E; Glynn RJ; Tsacogianis T; Kim DH J Am Geriatr Soc; 2023 Oct; 71(10):3110-3121. PubMed ID: 37345734 [TBL] [Abstract][Full Text] [Related]
13. Patient Perceptions and Familiarity With Medical Therapy for Heart Failure. Samsky MD; Lin L; Greene SJ; Lippmann SJ; Peterson PN; Heidenreich PA; Laskey WK; Yancy CW; Greiner MA; Hardy NC; Kavati A; Park S; Mentz RJ; Fonarow GC; O'Brien EC JAMA Cardiol; 2020 Mar; 5(3):292-299. PubMed ID: 31734700 [TBL] [Abstract][Full Text] [Related]
14. Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization. Bhagat AA; Greene SJ; Vaduganathan M; Fonarow GC; Butler J JACC Heart Fail; 2019 Jan; 7(1):1-12. PubMed ID: 30414818 [TBL] [Abstract][Full Text] [Related]
15. Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice. Savarese G; Lindberg F; Christodorescu RM; Ferrini M; Kumler T; Toutoutzas K; Dattilo G; Bayes-Genis A; Moura B; Amir O; Petrie MC; Seferovic P; Chioncel O; Metra M; Coats AJS; Rosano GMC Eur J Heart Fail; 2024 Jun; 26(6):1408-1418. PubMed ID: 38515385 [TBL] [Abstract][Full Text] [Related]
16. Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure. Tran RH; Aldemerdash A; Chang P; Sueta CA; Kaufman B; Asafu-Adjei J; Vardeny O; Daubert E; Alburikan KA; Kucharska-Newton AM; Stearns SC; Rodgers JE Pharmacotherapy; 2018 Apr; 38(4):406-416. PubMed ID: 29423950 [TBL] [Abstract][Full Text] [Related]
17. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction. Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488 [TBL] [Abstract][Full Text] [Related]
18. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial. Cox ZL; Zalawadiya SK; Simonato M; Redfors B; Zhou Z; Kotinkaduwa L; Zile MR; Udelson JE; Lim DS; Grayburn PA; Mack MJ; Abraham WT; Stone GW; Lindenfeld J JACC Heart Fail; 2023 Jul; 11(7):791-805. PubMed ID: 37115135 [TBL] [Abstract][Full Text] [Related]
19. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial. Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999 [TBL] [Abstract][Full Text] [Related]
20. Optimizing Guideline-Directed Medical Therapy During Hospitalization Improves Prognosis in Patients With Worsening Heart Failure Requiring Readmissions. Matsukawa R; Kabu K; Koga E; Hara A; Kisanuki H; Sada M; Okabe K; Okahara A; Tokutome M; Kawai S; Ogawa K; Matsuura H; Mukai Y Circ J; 2024 Aug; 88(9):1416-1424. PubMed ID: 39034132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]